| 摘要 |
The use of L-carnitine, some alkanoyl L-carnitines and the pharmacologically acceptable salts thereof is disclosed, in combination with long-chain alkanols such as polycosanols, or polycosanol-bearing natural products or extracts thereof for the prevention and treatment of diseases caused by abnormal lipid metabolism, such as atherosclerosis, hypercholesterolaemia, cardiovascular disorders and peripheral diabetic neuropathy. |
